813 related articles for article (PubMed ID: 16145413)
1. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Rademaker A; Lloyd GL; Gann P
J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
[TBL] [Abstract][Full Text] [Related]
2. [The autonomic nervous system function in benign prostatic hyperplasia].
Thor PJ; Mazur M; Furgała A; Worek M
Folia Med Cracov; 2006; 47(1-4):79-86. PubMed ID: 18038615
[TBL] [Abstract][Full Text] [Related]
3. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
[TBL] [Abstract][Full Text] [Related]
6. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
[TBL] [Abstract][Full Text] [Related]
7. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
8. Data from frequency-volume charts versus symptom scores and quality of life score in men with lower urinary tract symptoms due to benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Gisolf KW; Boon TA
Eur Urol; 2001 Jan; 39(1):42-7. PubMed ID: 11173938
[TBL] [Abstract][Full Text] [Related]
9. Tadalafil - a therapeutic option in the management of BPH-LUTS.
Carson CC; Rosenberg M; Kissel J; Wong DG
Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
[TBL] [Abstract][Full Text] [Related]
10. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
Lee JH; Kim Y; Park YW; Lee DG
J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive patient evaluation for benign prostatic hyperplasia.
Jepsen JV; Bruskewitz RC
Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
[TBL] [Abstract][Full Text] [Related]
12. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
[TBL] [Abstract][Full Text] [Related]
13. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.
Roehrborn CG; Oesterling JE; Auerbach S; Kaplan SA; Lloyd LK; Milam DE; Padley RJ
Urology; 1996 Feb; 47(2):159-68. PubMed ID: 8607227
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.
Trueman P; Hood SC; Nayak US; Mrazek MF
BJU Int; 1999 Mar; 83(4):410-5. PubMed ID: 10210562
[TBL] [Abstract][Full Text] [Related]
15. Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia.
Eckhardt MD; van Venrooij GE; Boon TA
Urology; 2001 Dec; 58(6):966-71. PubMed ID: 11744470
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
17. Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia.
Ullrich PM; Lutgendorf SK; Kreder KJ
Urology; 2007 Sep; 70(3):487-91; discussion 491-2. PubMed ID: 17905102
[TBL] [Abstract][Full Text] [Related]
18. Analysis and reliability of data from 24-hour frequency-volume charts in men with lower urinary tract symptoms due to benign prostatic hyperplasia.
Gisolf KW; van Venrooij GE; Eckhardt MD; Boon TA
Eur Urol; 2000 Jul; 38(1):45-52. PubMed ID: 10859441
[TBL] [Abstract][Full Text] [Related]
19. Measures of autonomic nervous system activity and lower urinary tract symptoms.
St Sauver JL; Sandroni P; Jacobson DJ; McGree ME; Lieber MM; Jacobsen SJ
Clin Auton Res; 2011 Feb; 21(1):61-4. PubMed ID: 20845055
[TBL] [Abstract][Full Text] [Related]
20. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]